Home
About
Overview
Sharing Data
ORCID
Help
History (7)
Norgestrienone
Ross River virus
Small molecule agonists of integrin CD11b/CD18 do not induce global conformational changes and are significantly better than activating antibodies in reducing vascular injury.
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
Implementation of miRNAs to Reduce In-Stent Restenosis in the Future.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Implementation of miRNAs to Reduce In-Stent Restenosis in the Future.
Implementation of miRNAs to Reduce In-Stent Restenosis in the Future. J Am Coll Cardiol. 2015 Jun 02; 65(21):2328-30.
View in:
PubMed
subject areas
Animals
Coronary Restenosis
Drug-Eluting Stents
Male
MicroRNAs
Vascular Remodeling
Vascular System Injuries
authors with profiles
Chunxiang (Kevin) Zhang
Gary L Schaer